CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Clinical trials for CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to prevent dangerous bleeding in cancer patients during treatment
Disease control Not yet recruitingThis study tests a drug called romiplostim N01 in cancer patients whose platelet levels drop dangerously low during chemotherapy and radiation. Low platelets can cause bleeding and delay cancer treatment. The drug is compared to a standard treatment to see if it can raise platele…
Matched conditions: CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: NA • Sponsor: Jun wang • Aim: Disease control
Last updated May 26, 2026 06:47 UTC
-
New hope for breast cancer patients: drug may prevent dangerous drop in blood platelets
Disease control Not yet recruitingThis study tests whether the drug hetrombopag can prevent or reduce low platelet counts (thrombocytopenia) caused by antibody-drug conjugate (ADC) treatments for breast cancer. About 72 adults with breast cancer will receive hetrombopag alongside their regular chemotherapy. The g…
Matched conditions: CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New drug may shield cancer patients from dangerous platelet drop
Disease control Not yet recruitingThis study tests whether the drug hetrombopag can prevent severe low platelet counts caused by chemotherapy in people with nasopharyngeal carcinoma. About 35 patients who had low platelets after their last chemo round will receive hetrombopag during their next cycles. The goal is…
Matched conditions: CTIT-CHEMOTHERAPY INDUCED THROMBOCYTOPENIA
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated May 11, 2026 20:50 UTC